Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of anle138b in Healthy Male and Female Subjects

NCT04208152 is registered in ClinicalTrials.gov with MODAG GmbH as lead sponsor.

NCT NCT04208152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04208152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of anle138b in Healthy Male and Female Subjects
Lead sponsor
MODAG GmbH
Phase
Phase 1
Overall status
Completed
Start date
December 6, 2019
Completion date
August 4, 2020
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers